N-LIfT shows potent cancer killing across multiple solid tumour types
LIfT BioSciences announces its N-LIfT cell therapy shows tumour destruction across five different solid tumour types in PDX tumouroid...
Welcome to LIfT BioSciences
LIfT BioSciences is developing a breakthrough allogeneic innate cell therapy platform that produces different types of Immunomodulatory Alpha Neutrophils (IMANs). LIfT's focus is on producing an exceptional type of anti-cancer alpha neutrophil with enhanced cytotoxic and immunomodulatory properties.
Our mission is to develop affordable curative therapies for solid tumours with high unmet medical need.
